DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Coleman R, Cameron D, Dodwell D. et al.
Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.
Lancet Oncol 2014;
15: 997-1006
We do not assume any responsibility for the contents of the web pages of other providers.